Main initial characteristics of 128 patients with diffuse large-cell lymphoma
| Characteristics . | No. (%) . |
|---|---|
| Performance status (ECOG > 2; n = 125)* | 58 (46) |
| B symptoms | 50 (39) |
| Ann Arbor stage | |
| I | 27 (21) |
| II | 34 (27) |
| III | 16 (13) |
| IV | 48 (38) |
| Bulky disease | 34 (25) |
| Primary extranodal origin (excluding Waldeyer ring) | 50 (39) |
| Bone marrow (+) | 22 (17) |
| High serum LDH (n = 115)* | 63 (55) |
| High serum β2-microglobulin (n = 72)* | 30 (42) |
| International Prognostic Index (n = 118)* | |
| Low risk | 37 (31) |
| Low/intermediate | 26 (22) |
| High/intermediate | 22 (19) |
| High risk | 33 (28) |
| Characteristics . | No. (%) . |
|---|---|
| Performance status (ECOG > 2; n = 125)* | 58 (46) |
| B symptoms | 50 (39) |
| Ann Arbor stage | |
| I | 27 (21) |
| II | 34 (27) |
| III | 16 (13) |
| IV | 48 (38) |
| Bulky disease | 34 (25) |
| Primary extranodal origin (excluding Waldeyer ring) | 50 (39) |
| Bone marrow (+) | 22 (17) |
| High serum LDH (n = 115)* | 63 (55) |
| High serum β2-microglobulin (n = 72)* | 30 (42) |
| International Prognostic Index (n = 118)* | |
| Low risk | 37 (31) |
| Low/intermediate | 26 (22) |
| High/intermediate | 22 (19) |
| High risk | 33 (28) |
The median age of the patients was 65 years (range, 22-93 years); 59 were male and 69 were female.
ECOG indicates Eastern Cooperative Oncology Group scale.
The n shown reflects the number of patients for whom data were available.